Frontlight ResearchEarly access
Trial site
Central India Cardiology and Research Institute
- 5running trials
- 2closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Obesity3 trials
- Chronic kidney disease2 trials
- Migraine2 trials
- Heart failure1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 37 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Eli Lilly and Company7 trials
Running trials
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
Active, not recruiting
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026